CAV1 and pulmonary arterial hypertension: Taken together, our results demonstrated that reduced serum Cav1 level may be a potential biomarker in IPAH diagnosis and could be used for differential diagnosis of pulmonary artery hypertension patients between idiopathic pulmonary hypertension and COPD.